You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccinia Virus

Showing 1 - 25 of 6,485
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Recombinant human IL-21 oncolytic vaccinia virus injection
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 21, 2023

Oncolytic Virotherapy Trial in St. Petersburg (Double Recombinant Vaccinia Virus VV-GMCSF-Lact)

Recruiting
  • Oncolytic Virotherapy
  • Double Recombinant Vaccinia Virus VV-GMCSF-Lact
  • St. Petersburg, Russian Federation
    N.N. Petrov National Medical Research Center of Oncology
May 11, 2022

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of

Completed
  • Smallpox
  • +3 more
  • VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
  • +3 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023

Healthy, Communicable Diseases Trial (Vaccinia Immune Globulin (Human))

Withdrawn
  • Healthy
  • Communicable Diseases
  • Vaccinia Immune Globulin (Human)
  • (no location specified)
Oct 28, 2021

Lung Cancer Trial in New York (GL-ONC1)

Active, not recruiting
  • Lung Cancer
  • GL-ONC1
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 7, 2022

HIV Trial in Rochester (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Rochester, New York
    Univ. of Rochester AVEG
Oct 26, 2021

Smallpox, Monkeypox, Cowpox Trial in Koltsovo, Novosibirsk (VAC?6 vaccine (107 PFU), VAC?6 vaccine (106 PFU), Live Smallpox

Completed
  • Smallpox
  • +3 more
  • VAC∆6 vaccine (10⁷ PFU)
  • +3 more
  • Koltsovo, Novosibirsk Region, Russian Federation
  • +1 more
Apr 25, 2023

Relapsed or Refractory B-cell Lymphoma Trial in Hangzhou (RGV004)

Not yet recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • RGV004
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 30, 2021

Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pexastimogene Devacirepvec (Pexa-Vec)
  • Cemiplimab
  • Irvine, California
  • +17 more
Oct 26, 2022

Ovarian Cancer Trial in Wuhan (KM1, Chemotherapy)

Not yet recruiting
  • Ovarian Cancer
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Jan 5, 2023

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

Local Progression or Metastatic Melanoma With Failed First-line Treatment Trial in Beijing (Pexa-Vec combined with ZKAB001,

Recruiting
  • Local Progression or Metastatic Melanoma With Failed First-line Treatment
  • Pexa-Vec combined with ZKAB001
  • ZKAB001 monotherapy
  • Beijing, China
    Beijing Cancer Hospital
Mar 30, 2022

HIV Trial in Saint Louis, Pittsburgh, Nashville (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +2 more
Oct 27, 2021

HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • HIV Seronegativity
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +1 more
Oct 28, 2021

HIV Trial in Saint Louis, Rochester, Nashville (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

Hepatocellular Carinoma Trial in Korea, Republic of, Spain, United States (JX-594 recombinant vaccina GM-CSF)

Completed
Has Results
  • Hepatocellular Carinoma
  • JX-594 recombinant vaccina GM-CSF
  • Scottsdale, Arizona
  • +4 more
Dec 29, 2020

HIV Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +1 more
Oct 28, 2021

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Monkeypox Virus Infection Trial in Boende (IMVAMUNE)

Active, not recruiting
  • Monkeypox Virus Infection
  • IMVAMUNE
  • Boende, Tshuapa, Congo, The Democratic Republic of the
    Tshuapa site
May 11, 2022

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Advanced Malignant Solid Tumors Trial in Shenyang, Shanghai (T601, T601+5-FC)

Recruiting
  • Advanced Malignant Solid Tumors
  • T601
  • T601+5-FC
  • Shenyang, Liaoning, China
  • +1 more
Dec 4, 2020

Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV-MVA Triplex
  • Placebo
  • Birmingham, Alabama
  • +11 more
Jun 20, 2022

Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +18 more
  • Basking Ridge, New Jersey
  • +6 more
May 18, 2023

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,

Completed
  • Smallpox
  • +3 more
  • NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
  • +5 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023

Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)

Completed
  • Human Immunodeficiency Virus
  • Ad26.Mos4.HIV
  • +3 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 7, 2022